BACKGROUND: Existing publicly reported readmission measures are condition-specific, representing less than 20% of adult hospitalizations. An all-condition measure may better measure quality and promote innovation. OBJECTIVE: To develop an all-condition, hospital-wide readmission measure. DESIGN: Measure development study. SETTING: 4821 U.S. hospitals. PATIENTS: Medicare fee-for-service beneficiaries aged 65 years or older. MEASUREMENTS: Hospital-level, risk-standardized unplanned readmissions within 30 days of discharge. The measure uses Medicare fee-for-service claims and is a composite of 5 specialty-based, risk-standardized rates for medicine, surgery/gynecology, cardiorespiratory, cardiovascular, and neurology cohorts. The 2007-2008 admissions were randomly split for development and validation. Models were adjusted for age, principal diagnosis, and comorbid conditions. Calibration in Medicare and all-payer data was examined, and hospital rankings in the development and validation samples were compared. RESULTS: The development data set contained 8 018 949 admissions associated with 1 276 165 unplanned readmissions (15.9%). The median hospital risk-standardized unplanned readmission rate was 15.8 (range, 11.6 to 21.9). The 5 specialty cohort models accurately predicted readmission risk in both Medicare and all-payer data sets for average-risk patients but slightly overestimated readmission risk at the extremes. Overall hospital risk-standardized readmission rates did not differ statistically in the split samples (P = 0.71 for difference in rank), and 76% of hospitals' validation-set rankings were within 2 deciles of the development rank (24% were more than 2 deciles). Of hospitals ranking in the top or bottom deciles, 90% remained within 2 deciles (10% were more than 2 deciles) and 82% remained within 1 decile (18% were more than 1 decile). LIMITATION: Risk adjustment was limited to that available in claims data. CONCLUSION: A claims-based, hospital-wide unplanned readmission measure for profiling hospitals produced reasonably consistent results in different data sets and was similarly calibrated in both Medicare and all-payer data. PRIMARY FUNDING SOURCE: Centers for Medicare & Medicaid Services.
BACKGROUND: Existing publicly reported readmission measures are condition-specific, representing less than 20% of adult hospitalizations. An all-condition measure may better measure quality and promote innovation. OBJECTIVE: To develop an all-condition, hospital-wide readmission measure. DESIGN: Measure development study. SETTING: 4821 U.S. hospitals. PATIENTS: Medicare fee-for-service beneficiaries aged 65 years or older. MEASUREMENTS: Hospital-level, risk-standardized unplanned readmissions within 30 days of discharge. The measure uses Medicare fee-for-service claims and is a composite of 5 specialty-based, risk-standardized rates for medicine, surgery/gynecology, cardiorespiratory, cardiovascular, and neurology cohorts. The 2007-2008 admissions were randomly split for development and validation. Models were adjusted for age, principal diagnosis, and comorbid conditions. Calibration in Medicare and all-payer data was examined, and hospital rankings in the development and validation samples were compared. RESULTS: The development data set contained 8 018 949 admissions associated with 1 276 165 unplanned readmissions (15.9%). The median hospital risk-standardized unplanned readmission rate was 15.8 (range, 11.6 to 21.9). The 5 specialty cohort models accurately predicted readmission risk in both Medicare and all-payer data sets for average-risk patients but slightly overestimated readmission risk at the extremes. Overall hospital risk-standardized readmission rates did not differ statistically in the split samples (P = 0.71 for difference in rank), and 76% of hospitals' validation-set rankings were within 2 deciles of the development rank (24% were more than 2 deciles). Of hospitals ranking in the top or bottom deciles, 90% remained within 2 deciles (10% were more than 2 deciles) and 82% remained within 1 decile (18% were more than 1 decile). LIMITATION: Risk adjustment was limited to that available in claims data. CONCLUSION: A claims-based, hospital-wide unplanned readmission measure for profiling hospitals produced reasonably consistent results in different data sets and was similarly calibrated in both Medicare and all-payer data. PRIMARY FUNDING SOURCE: Centers for Medicare & Medicaid Services.
Authors: Harlan M Krumholz; Ralph G Brindis; John E Brush; David J Cohen; Andrew J Epstein; Karen Furie; George Howard; Eric D Peterson; Saif S Rathore; Sidney C Smith; John A Spertus; Yun Wang; Sharon-Lise T Normand Journal: Circulation Date: 2005-12-19 Impact factor: 29.690
Authors: Gregory C Pope; John Kautter; Randall P Ellis; Arlene S Ash; John Z Ayanian; Lisa I Lezzoni; Melvin J Ingber; Jesse M Levy; John Robst Journal: Health Care Financ Rev Date: 2004
Authors: Michael P Thompson; Cameron M Kaplan; Yu Cao; Gloria J Bazzoli; Teresa M Waters Journal: Health Serv Res Date: 2016-10-21 Impact factor: 3.402
Authors: Leora I Horwitz; Susannah M Bernheim; Joseph S Ross; Jeph Herrin; Jacqueline N Grady; Harlan M Krumholz; Elizabeth E Drye; Zhenqiu Lin Journal: Med Care Date: 2017-05 Impact factor: 2.983
Authors: Oanh Kieu Nguyen; Anil N Makam; Christopher Clark; Song Zhang; Bin Xie; Ferdinand Velasco; Ruben Amarasingham; Ethan A Halm Journal: J Hosp Med Date: 2016-02-29 Impact factor: 2.960
Authors: Hrishikesh Chakraborty; Robert Neal Axon; Jordan Brittingham; Genevieve Ray Lyons; Laura Cole; Christine B Turley Journal: Health Serv Res Date: 2016-09-28 Impact factor: 3.402
Authors: Leora I Horwitz; Jacqueline N Grady; Dorothy B Cohen; Zhenqiu Lin; Mark Volpe; Chi K Ngo; Andrew L Masica; Theodore Long; Jessica Wang; Megan Keenan; Julia Montague; Lisa G Suter; Joseph S Ross; Elizabeth E Drye; Harlan M Krumholz; Susannah M Bernheim Journal: J Hosp Med Date: 2015-07-07 Impact factor: 2.960
Authors: Harlan M Krumholz; Kun Wang; Zhenqiu Lin; Kumar Dharmarajan; Leora I Horwitz; Joseph S Ross; Elizabeth E Drye; Susannah M Bernheim; Sharon-Lise T Normand Journal: N Engl J Med Date: 2017-09-14 Impact factor: 91.245